Evogene Ltd 20-F for FY2022
Evogene Ltd. (EVGN)
20-F
2023-03-30
For: 2022-12-31
View Original
Added on
April 05, 2026
About this 20-F
Evogene Ltd filed this 20-F on March 30, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.68M
- up 80.1% from $930K a year earlier
- Net loss
- $26.64M
- compared with a net loss of $27.79M a year earlier
- Diluted EPS
- -$0.65
- compared with -$0.69 a year earlier